Cogent Biosciences is a biotechnology company committed to developing precision therapies for genetically defined diseases. Their lead product, bezuclastinib, targets specific mutations in the KIT receptor tyrosine kinase, addressing critical conditions like systemic mastocytosis and gastrointestinal stromal tumors. With impressive clinical trial outcomes, Cogent is at the forefront of meeting the needs of patients facing serious health challenges.
No jobs found. Subscribe below to get notified when we find something for you.
Searching